Thye Dirk

Average Profitability
<0.0001%
Insider Buys Quantity
4
Insider Buys Sum
$317,455.00
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Thye Dirk

According to the SEC Form 4 filings, Thye Dirk, being in a position of

  1. CEO AND CHIEF MEDICAL OFFICER at Quince Therapeutics, Inc.,
    оver the last 12 months, has bought 154500 shares for $107,375, and sold 0 shares,
    over all time since 2023-08-08, has bought 322500 shares for $317,455, and sold 0 shares.

The largest purchase of all time was on 2023-08-10 and amounted to 88000 shares of Quince Therapeutics, Inc. for $110,880.

Biography of Thye Dirk

No biography is available at this moment.

2024-08-30PurchaseQuince Therapeutics, Inc.
QNCX
CEO AND CHIEF MEDICAL OFFICER
77,000
0.1802%
$0.70$53,900+11.43%
2024-08-29PurchaseQuince Therapeutics, Inc.
QNCX
CEO AND CHIEF MEDICAL OFFICER
77,500
0.1782%
$0.69$53,475+10.63%
2023-08-10PurchaseQuince Therapeutics, Inc.
QNCX
Chief Executive Officer
88,000
0.2461%
$1.26$110,880-14.52%
2023-08-08PurchaseQuince Therapeutics, Inc.
QNCX
Chief Executive Officer
80,000
0.2238%
$1.24$99,200-13.11%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.